September 21, 2007

Lynn L. Bergeson, co-author, “TSCA and Engineered Nanoscale Substances,” Sustainable Development Law and Policy, Fall 2007.

Nanotechnology is now the subject of much excitement and attention, with applications proliferating quickly. Thus, engineered nanoscale materials’ (“ENM”) implications for human health and the environment, and the critical need for governments throughout the world to get the policy and regulatory framework right has garnered much attention. Most would agree that the ultimate goal for society is to enable nanotechnology to realize its potential while effectively addressing the pertinent...
September 19, 2007

ACGIH Will Present Webinar on Nanotechnology Health and Safety

The American Conference of Governmental Industrial Hygienists (ACGIH) will hold a webinar entitled “Nanotechnology Health and Safety: Case Studies in the Occupational Setting” on December 4, 2007. The webinar will discuss the uncertainties associated with the hazards and potential risks of working with engineered nanoparticles; describe ways to help manage exposure to engineered nanoparticles; and illustrate how occupational health and safety controls, both engineering and...
September 17, 2007

Canada Publishes Proposed Regulatory Framework for Nanomaterials Under CEPA

Environment Canada (EC) and Health Canada (HC) have released a document entitled Proposed Regulatory Framework for Nanomaterials Under the Canadian Environmental Protection Act, 1999 (Proposed Framework). EC/HC will hold a public workshop for stakeholders regarding the Proposed Framework on September 27, 2007, in Toronto. At the workshop, EC/HC will gather comments from participating stakeholders through discussion groups and plenary sessions. EC/HC will invite all...
September 12, 2007

Greenpeace Releases Activists’ Guide to REACH, Which Addresses Nanomaterials

On August 30, 2007, Greenpeace International (Greenpeace) issued a report entitled Navigating REACH: An Activists’ Guide To Using and Improving the New EU Chemicals Legislation (Guide), which is intended to explain how the European Union’s (EU) Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation will work, what main issues are at stake, and how the law will be implemented. The Guide highlights provisions that non-governmental...
September 10, 2007

Environmental Health Perspectives Publishes Study Regarding Pharmacokinetics of Quantum Dots

The September 1, 2007, issue of Environmental Health Perspectives includes an article entitled “Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment.”  The purpose of the study was to assess the tissue disposition and pharmacokinetics of quantum dots (QD705) in mice.  According to the article, the plasma half-life of QD705 in mice was short (18.5 hours), but analyses revealed QD705 persisted and even...
August 31, 2007

Nanoparticle Flow Processing Consortium Files Notifications with DOJ and FTC

On August 27, 2007, the Antitrust Division of the Department of Justice (DOJ) published a notice in the Federal Register announcing that, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. Sections 4301 et seq., the Nanoparticle Flow Processing Consortium has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission (FTC) disclosing (1) the identities of the parties to the venture and (2)...
August 30, 2007

Reader-Friendly Version of 2006 EC Report Available

The European Commission (EC) Directorate General for Health and Consumer Protection retained GreenFacts to summarize the EC’s 2006 report entitled Modified Opinion (After Public Consultation) on the Appropriateness of Existing Methodologies to Assess the Potential Risks Associated with Engineered and Adventitious Products of Nanotechnologies. According to GreenFacts, the EC’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) wrote its Opinion for a...
August 24, 2007

FDA Releases Proposed Rule Regarding Sunscreens

Yesterday the Food and Drug Administration (FDA) released a proposed rule that would amend the final monograph for over-the-counter (OTC) sunscreen drug products as part of FDA’s ongoing review of OTC drug products. The proposed rule addresses formulation, labeling, and testing requirements for both ultraviolet B (UVB) and ultraviolet A (UVA) radiation protection, would introduce four-star rating system for the level of UVA protection, and would require a warning...
August 22, 2007

President’s Council on Bioethics Will Discuss Ethical Issues Associated with Nanotechnology

On August 14, 2007, the Department of Health and Human Services (DHHS) published a Federal Register notice announcing the 30th meeting of the President’s Council on Bioethics. The agenda items listed in the notice include “continue the exploratory phase of a potential inquiry into ethical issues associated with nanotechnology with expert presentations and Council discussions.” The meeting will be September 6-7, 2007....